颈动脉斑块可预测类风湿关节炎患者的心血管事件:5年前瞻性随访研究
该研究纳入327例无糖尿病、慢性肾病或心血管事件史的类风湿关节炎(RA)患者,2012–2013年行颈动脉超声并计算EULAR mSCORE,随访5年。结果发现颈动脉斑块是心血管事件和死亡的预测因素,其预测能力优于mSCORE,QRISK3联合斑块模型也表现较好。
要点
- 颈动脉斑块预测RA患者心血管事件(HR 5.25,95%CI 1.41–19.50,p=0.01)。
- 颈动脉斑块联合QRISK3模型对心血管事件预测能力优于mSCORE。
- mSCORE在RA患者中预测死亡或心血管事件的能力较弱。
核心结论
- 颈动脉斑块的存在可预测RA患者心血管事件和死亡的发生。
- 颈动脉斑块和QRISK3的预测能力高于mSCORE。
研究设计与样本
- 前瞻性定义的基于人群的RA起始队列,共327例连续患者。
- 2012–2013年行颈动脉超声,并基于基线数据回顾性计算EULAR mSCORE和QRISK3。
- 进行5年前瞻性随访,采用生存分析模型。
主要发现
- 随访1,984.25患者年,23例死亡,27例发生心血管事件。
- 线性化死亡率为1.16/100患者年(95%CI 0.74–1.73)。
- 调整年龄、性别和病程后,颈动脉斑块预测死亡的HR为6.10(95%CI 0.74–50.0;p=0.09)。
- 颈动脉斑块预测心血管事件的HR为5.25(95%CI 1.41–19.50;p=0.01)。
- 颈动脉斑块联合QRISK3模型中,QRISK3每增加1%预测心血管事件的HR为1.03(95%CI 0.99–1.07;p=0.12)。
关键数值与推荐
- 颈动脉斑块预测心血管事件:HR 5.25(95%CI 1.41–19.50;p=0.01)。
- 颈动脉斑块联合QRISK3预测心血管事件:斑块HR 5.13(95%CI 1.36–19.3;p=0.02),QRISK3每1% HR 1.03(95%CI 0.99–1.07;p=0.12)。
- 颈动脉斑块联合QRISK3预测死亡:斑块HR 6.12(95%CI 0.74–50.5;p=0.09),QRISK3每1% HR 1.03(95%CI 0.99–1.07;p=0.11)。
临床怎么用
- 在RA患者心血管风险评估中可考虑颈动脉超声检测斑块。
- 颈动脉斑块联合QRISK3可能优于单用mSCORE进行风险分层。
局限性
- mSCORE和QRISK3为回顾性计算,基于基线数据。
- 部分预测模型置信区间较宽且未达统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate if the Systematic Coronary Risk Evaluation (SCORE) and the QRISK3 algorithms as well as the carotid ultrasound are useful predictors of cardiovascular (CV) events and death in a prospectively defined population-based rheumatoid arthritis (RA) inception cohort. METHODS: A set of 327 consecutive RA patients without history of diabetes, chronic kidney disease or CV events were studied by carotid ultrasound between 2012 and 2013. At that time, CV risk was calculated according to the modified EULAR systematic coronary risk evaluation (mSCORE) for RA. A five-year prospective follow-up study was conducted by survival analysis models. The EULAR mSCORE based on the 2015/2016 updated EULAR recommendations and the QRISK3 algorithms were retrospectively tested using baseline data. RESULTS: After 1,984.25 patient-years of follow-up, 23 had died and 27 had experienced CV events. Linearized mortality rate was 1.16/100 patient-years (95% confidence interval [CI]: 0.74--1.73). Adjusting for age, gender and disease duration, a model with carotid plaques (Hazard ratio [HR]: 6.10 [95% CI:0.74--50.0]; p = 0.09) and another model with carotid plaques and QRISK3 (HR for carotid plaques: 6.12 [95% CI: 0.74--50.5]; p = 0.09 and HR for each 1% in QRISK3: 1.03 [95% CI: 0.99--1.07], p = 0.11, respectively were the best predictors of death whereas a model with carotid plaques (HR: 5.25 [95% CI:1.41--19.50]; p = 0.01) and another model with carotid plaques and QRISK3 (HR for carotid plaques: 5.13 [95% CI: 1.36--19.3]; p = 0.02 and HR for each 1% in QRISK3: 1.03 [95% CI: 0.99--1.07], p = 0.12, respectively, were the best predictors of CV events. In contrast, the mSCORE was a weaker predictor of the risk of death or CV events. CONCLUSIONS: The presence of carotid plaques predicts the development of CV events and death in patients with RA. The predictable capacity of carotid plaques and QRISK3 is higher than that of mSCORE in RA patients.
引用
- Corrales A, Vegas-Revenga N, Rueda-Gotor J, et al. Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study. Semin Arthritis Rheum. 2020. PMID: 32416998. doi:10.1016/j.semarthrit.2020.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。